Masahito Tokunaga
Kagoshima, 8900064, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation.
Journal: Bone marrow transplantation
Published: March 18, 2026
Impact of disease status and general condition on changes in physical function before and after allogeneic hematopoietic stem cell transplantation.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 18, 2026
Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis.
Journal: Scientific reports
Published: March 16, 2026
Haploidentical transplantation versus umbilical cord blood transplantation in acute myeloid leukemia with measurable residual disease.
Journal: Cytotherapy
Published: March 09, 2026
Utility of Flow Cytometry for Prognostic Prediction in Adult T-Cell Leukemia/Lymphoma.
Journal: EJHaem
Published: January 21, 2026
Can Cord Blood Unit Selection Improve Outcomes After Single-Unit Unrelated Cord Blood Transplantation for Non-Remission Acute Myeloid Leukemia?
Journal: Transplantation and cellular therapy
Published: January 13, 2026
Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease.
Journal: Cytotherapy
Published: January 11, 2026
Impact of antiviral therapies on survival in patients with HHV-6B encephalitis after cord blood transplantation: a real-world study.
Journal: Bone marrow transplantation
Published: November 26, 2025
Second Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma: A Nationwide Registry Analysis.
Journal: Transplantation and cellular therapy
Published: November 14, 2025
Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan.
Journal: Bone marrow transplantation
Published: October 23, 2025
Application Timing-Dependent Impact of Donor Source on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma.
Journal: Hematological oncology
Published: October 13, 2025
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experience.
Journal: British journal of haematology
Published: October 08, 2025
Last Updated: 09/26/2026